T cell receptor beta joining 2-5 (TRBJ2-5)

T cell receptor beta joining 2-5 (TRBJ2-5) is a gene segment that encodes the joining region (J) in the variable domain of the beta chain of the T cell receptor (TCR)[3][5][4]. The TCR is a heterodimeric protein on T lymphocytes responsible for antigen recognition via peptides presented by major histocompatibility complex (MHC) molecules[6]. During T cell development, the TCR beta chain is formed by somatic recombination of variable (V), diversity (D), and joining (J) gene segments; TRBJ2-5 is one of the 12 human beta-chain J segments that help generate the highly diverse complementarity-determining region 3 (CDR3), which is the principal site for antigen contact[3][5]. TRBJ2-5 does not function as a receptor or protein independently but as a component of the genetic code allowing TCR diversity essential for adaptive immunity. Mutations or polymorphisms in TRBJ genes may indirectly impact immune responses, but there is no evidence that TRBJ2-5 directly serves as a pharmacologic, therapeutic, or diagnostic target[3][5][2]. Additional context and clarifications: - While the broader T cell receptor is a recognized immunotherapeutic target (notably in TCR-engineered T cell therapies), individual joining segments like TRBJ2-5 are not used as direct drug targets or clinical biomarkers[5][4][3][6]. - The correct molecular class for TRBJ2-5 is “gene segment” rather than full protein, receptor, or enzyme. - Some databases may list nomenclature variants (e.g., TRBJ25, TCRBJ2S5), but “TRBJ2-5” is standardized[1]. Summary: TRBJ2-5 is a gene segment, not an independent protein or classic drug target, and therefore information about drug interactions, mechanisms of action, or biomarker status is not applicable. Its significance is in contributing to the diversity of the TCR beta chain as part of immune repertoire generation.

Other names

TRBJ2-5TRBJ25TCRBJ2S5